Foxo Technologies Inc
OTC:FOXO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Meituan
HKEX:3690
|
CN |
|
AKA Brands Holding Corp
NYSE:AKA
|
US |
Foxo Technologies Inc
Cash from Operating Activities
Foxo Technologies Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Foxo Technologies Inc
OTC:FOXO
|
Cash from Operating Activities
-$2.8m
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Salesforce Inc
NYSE:CRM
|
Cash from Operating Activities
$15B
|
CAGR 3-Years
28%
|
CAGR 5-Years
26%
|
CAGR 10-Years
25%
|
|
|
Palantir Technologies Inc
NASDAQ:PLTR
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
112%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Applovin Corp
NASDAQ:APP
|
Cash from Operating Activities
$4B
|
CAGR 3-Years
113%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
|
Intuit Inc
NASDAQ:INTU
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
22%
|
CAGR 10-Years
17%
|
|
|
Adobe Inc
NASDAQ:ADBE
|
Cash from Operating Activities
$10.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
|
Foxo Technologies Inc
Glance View
FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota and currently employs 24 full-time employees. The company went IPO on 2020-12-11. The firm is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The firm operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.
See Also
What is Foxo Technologies Inc's Cash from Operating Activities?
Cash from Operating Activities
-2.8m
USD
Based on the financial report for Dec 31, 2024, Foxo Technologies Inc's Cash from Operating Activities amounts to -2.8m USD.
What is Foxo Technologies Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
43%
Over the last year, the Cash from Operating Activities growth was 57%. The average annual Cash from Operating Activities growth rates for Foxo Technologies Inc have been 43% over the past three years .
